Maxalac Lactating Cow

For broad-spectrum control of mastitis-causing bacteria (including penicillin-resistant strains) in lactating dairy cattle

Size: 20 x 3 gram syringes 

Dosage and Administration

Wear gloves when infusing the treatment.

Before infusion the teat should be thoroughly cleaned and disinfected. The contents of one syringe should be infused into the teat canal of each infected quarter every 12 hours, after each of three successive milkings.

  1. After milking is complete, thoroughly clean and disinfect the end of the teat (e.g. with cotton wool soaked in alcohol).
  2. Hold the barrel of the syringe firmly in one hand and gently twist and pull the protective cap in a straight line to remove it, taking care not to contaminate the nozzle.
  3. Insert the nozzle fully into the teat canal and apply steady pressure on the syringe plunger until the full dose has been delivered. Holding the end of the teat with one hand, gently massage upwards with the other to aid dispersion of the antibiotic into the quarter.
  4. After infusion it is advisable to dip the teat into an antiseptic preparation specifically designed for this purpose.

Active Constituent(s)

Each syringe contains 250 mg cefuroxime (as cefuroxime sodium)

Indications

For the treatment of clinical mastitis caused by the following pathogens: Staphylococcus spp., Staphylococcus aureus, including penicillin resistant spp., Streptococcus agalacatiae, Streptococcus dysgalactiae, Streptococcus uberis, Escherichia coli, Corynebacterium spp. (including Arcanobacterium pyogenes). The antibiotic, cefuroxime, is also active against other organisms recovered from the bovine udder including Klebsiella spp., Citrobacter spp., Enterobacter spp. and Micrococcus spp. MAXALAC® L.C. is therefore suitable for the treatment of clinical mastitis caused by all the major mastitis pathogens.